| P2093 | author name string | Russell N | |
| | Pallis M | |
| P2860 | cites work | Inhibition of calcineurin phosphatase activity by a calcineurin B homologous protein | Q22010915 |
| | NF-kappaB induces expression of the Bcl-2 homologue A1/Bfl-1 to preferentially suppress chemotherapy-induced apoptosis | Q24554454 |
| | Accumulation of glucosylceramides in multidrug-resistant cancer cells | Q28284394 |
| | Agents that reverse multidrug resistance, tamoxifen, verapamil, and cyclosporin A, block glycosphingolipid metabolism by inhibiting ceramide glycosylation in human cancer cells | Q28301485 |
| | TNF- and cancer therapy-induced apoptosis: potentiation by inhibition of NF-kappaB | Q29614706 |
| | Mitoxantrone, etoposide, and cytarabine with or without valspodar in patients with relapsed or refractory acute myeloid leukemia and high-risk myelodysplastic syndrome: a phase III trial (E2995) | Q33758413 |
| | A role for P-glycoprotein in regulating cell death | Q33918906 |
| | The multidrug transporter, P-glycoprotein, actively mediates cholesterol redistribution in the cell membrane | Q34074379 |
| | P-glycoprotein in acute myeloid leukaemia: therapeutic implications of its association with both a multidrug-resistant and an apoptosis-resistant phenotype | Q34142289 |
| | Changes in lipid and protein constituents of rafts and caveolae in multidrug resistant cancer cells and their functional consequences | Q34153467 |
| | P-glycoprotein is implicated in the inhibition of ceramide-induced apoptosis in TF-1 acute myeloid leukemia cells by modulation of the glucosylceramide synthase pathway | Q34386376 |
| | Preferential induction of apoptosis for primary human leukemic stem cells | Q34415832 |
| | The drug efflux protein, P-glycoprotein, additionally protects drug-resistant tumor cells from multiple forms of caspase-dependent apoptosis | Q36506556 |
| | ATP-binding cassette transporters are enriched in non-caveolar detergent-insoluble glycosphingolipid-enriched membrane domains (DIGs) in human multidrug-resistant cancer cells | Q40615235 |
| | SDZ PSC 833 the drug resistance modulator activates cellular ceramide formation by a pathway independent of P-glycoprotein | Q40890980 |
| | Retroviral transfection of Madin-Darby canine kidney cells with human MDR1 results in a major increase in globotriaosylceramide and 10(5)- to 10(6)-fold increased cell sensitivity to verocytotoxin. Role of p-glycoprotein in glycolipid synthesis | Q40897842 |
| | Human MDR 1 protein overexpression delays the apoptotic cascade in Chinese hamster ovary fibroblasts. | Q41091588 |
| | A comparison of the effect of the 3-hydroxy-3-methylglutaryl coenzyme A (HMG-CoA) reductase inhibitors simvastatin, lovastatin and pravastatin on leukaemic and normal bone marrow progenitors | Q41129665 |
| | Comparison of 'sequential' versus 'standard' chemotherapy as re-induction treatment, with or without cyclosporine, in refractory/relapsed acute myeloid leukaemia (AML): results of the UK Medical Research Council AML-R trial | Q43622754 |
| | Multidrug-resistance phenotype and clinical responses to gemtuzumab ozogamicin | Q43700140 |
| | Nuclear factor-kappaB is constitutively activated in primitive human acute myelogenous leukemia cells | Q43757315 |
| | Benefit of cyclosporine modulation of drug resistance in patients with poor-risk acute myeloid leukemia: a Southwest Oncology Group study | Q43806484 |
| | Protein kinase Czeta mediated Raf-1/extracellular-regulated kinase activation by daunorubicin | Q44198531 |
| | Cholesterol-modulating agents kill acute myeloid leukemia cells and sensitize them to therapeutics by blocking adaptive cholesterol responses | Q44265497 |
| | Quinine as a multidrug resistance inhibitor: a phase 3 multicentric randomized study in adult de novo acute myelogenous leukemia | Q44381147 |
| | Anti-P-glycoprotein antibody-induced apoptosis of activated peripheral blood lymphocytes: a possible role of P-glycoprotein in lymphocyte survival | Q46846341 |
| | Altered sphingolipid metabolism in multidrug-resistant ovarian cancer cells is due to uncoupling of glycolipid biosynthesis in the Golgi apparatus. | Q53969390 |
| | Increased sensitivity of multidrug-resistant myeloid leukemia cell lines to lovastatin. | Q54040702 |
| | P-glycoprotein and terminal transferase expression identify prognostic subsets within cytogenetic risk classes in acute myeloid leukemia. | Q54091772 |
| | Multidrug resistance in leukemia. | Q54124235 |
| | Quinine improves the results of intensive chemotherapy in myelodysplastic syndromes expressing P glycoprotein: results of a randomized study. | Q54125443 |
| | Contrasting in vitro effects for the combination of fludarabine, cytosine arabinoside (Ara-C) and granulocyte colony-stimulating factor (FLAG) compared with daunorubicin and Ara-C in P-glycoprotein-positive and P-glycoprotein-negative acute myelobla | Q73309598 |
| | Use of standardized flow cytometric determinants of multidrug resistance to analyse response to remission induction chemotherapy in patients with acute myeloblastic leukaemia | Q74527903 |
| | Up-regulation of caveolae and caveolar constituents in multidrug-resistant cancer cells | Q77604359 |
| P433 | issue | 12 | |
| P921 | main subject | leukemia | Q29496 |
| P304 | page(s) | 1927-1930 | |
| P577 | publication date | 2004-12-01 | |
| P1433 | published in | Leukemia | Q6534498 |
| P1476 | title | Strategies for overcoming p-glycoprotein-mediated drug resistance in acute myeloblastic leukaemia | |
| P478 | volume | 18 | |